La Maison Partners
VC Fund
Paris, France
La Maison Partners is a venture capital fund that invests in industry, technology, and finance. The fund supports its portfolio companies with its strong relationship network and by leveraging synergies with its shareholders, which enables collaboration with European industries. La Maison Partners was founded in 2014 and is headquartered inParis, France.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries La Maison Partners invests in
FinTechFinancial ServicesInformation TechnologySoftwareArtificial Intelligence
Stages La Maison Partners invests in
Series BSeries CSeries ASeries DVenture - Series Unknown
Countries La Maison Partners invests in
United StatesFranceIsraelSingaporeThe Netherlands
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Isabelle Amiel-Azoulai
|
|||
Marc Lévy
|
|||
Michel Cicurel
|
|||
Investment Focus
Industry
- FinTech 6 (33%)
- Financial Services 5 (28%)
- Information Technology 5 (28%)
- Software 4 (22%)
- Artificial Intelligence 4 (22%)
Stage
- Series B 5 (28%)
- Series C 5 (28%)
- Series A 2 (11%)
- Series D 2 (11%)
- Venture - Series Unknown 2 (11%)
Country
- United States 6 (33%)
- France 4 (22%)
- Israel 4 (22%)
- Singapore 1 (6%)
- The Netherlands 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Isabelle Amiel-Azoulai
Founding Partner
|
Founding Partner | Total investments: 4 | Find email | |
|
Marc Lévy
Founding Partner
|
Founding Partner | Total investments: 1 | Find email | |
|
Michel Cicurel
Founding Partner
|
Founding Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Defacto
|
Defacto is a fintech firm that offers credit infrastructure using an API for small and medium companies. Defacto is an embedded finance product, | $18.9M / Venture - Series Unknown / Sep 17, 2025 | |
Supervizor
|
Supervizor rises from ten years of R&D, assessing 130M of accounting schemes from +60,000 companies to list all your practices. As a result, it detects errors, frauds and atypical accounting procedures without any setup. More than 1000 companies around the world trust our Plug&Play technology to digitize their Audit and Internal Control,monitor risks of questions being asked by legal auditors and tax inspector in order to analyze all their subsidiaries in a flash.Supervizors’ purpose is to improve continuously the quality, accuracy, and efficiency of Accounting & Internal Control by automating controls within a unified cloud or On premise platform. | $21.7M / Series A / May 28, 2024 | |
Igloo
|
Igloo, previously known as “Axinan”, is the first full-stack insurtech firm to emerge from Singapore. It has offices in Singapore, Indonesia, Malaysia, Thailand, Philippines and Australia, and tech centres are located in China and Taiwan. With a mission of making insurance accessible for all, the firm leverages big data, real-time risk assessmentand end-to-end automated claims management to create B2B2C insurance solutions for platform companies and insurance companies. Igloo’s insurance solutions enable companies to eliminate their exposure to operational risk, create new revenue streams and optimise and enhance existing products and services. | $36M / Series C / Dec 04, 2023 | |
Indy
|
Indy offers end-to-end and advanced AI-powered accounting software. Indy is an accounting robot that aims to automate the accounting of freelancers and professionals. It is an accounting robot for the liberal professions. It automates the management of accounting, recovers bank entries to turn them into accounting lines, and sends tax returnsdirectly to an AGM.It was founded in 2016 as Georges by Côme Fouques, Pablo Larvor, Romain Koenig, and Adrien Plat to simplify independent accounting, which is certainly simple but repetitive and time-consuming. | $43.8M / Series C / Nov 20, 2023 | |
Inato
|
Inato automates data structuring and analysis, cross-checks data sources, and provides insights on this data. It features a tool for collecting and analyzing data used in clinical trials, Inato’s AI-powered platform enables pharmaceutical companies to drastically reduce drug development costs. By accelerating clinical trials, Inato helps newtherapies arrive to patients faster, and at lower prices | $20M / Series A / Mar 29, 2023 | |
|
Igloo
|
Igloo, previously known as “Axinan”, is the first full-stack insurtech firm to emerge from Singapore. It has offices in Singapore, Indonesia, Malaysia, Thailand, Philippines and Australia, and tech centres are located in China and Taiwan. With a mission of making insurance accessible for all, the firm leverages big data, real-time risk assessmentand end-to-end automated claims management to create B2B2C insurance solutions for platform companies and insurance companies. Igloo’s insurance solutions enable companies to eliminate their exposure to operational risk, create new revenue streams and optimise and enhance existing products and services. | $27M / Series B / Nov 28, 2022 | |
Jiko
|
Jiko is a new type of bank built on US Treasury bills to unlock unprecedented yield, safety, and scale through direct products and an embedded finance API. Jiko removes the limits of traditional banking to create a new paradigm for building financial success at the scale and speed of today’s economy. Headquartered in San Francisco with offices inNYC and Reykjavik, Jiko's vertically integrated financial institution combines its nationally chartered bank and registered broker-dealer to hold cash as T-bills – all in safe custody. Learn more at www.jiko.com. | $40M / Series B / Oct 06, 2022 | |
Taranis
|
Taranis is a leading precision agriculture intelligence platform that uses sophisticated computer vision, data science, and deep learning algorithms to effectively monitor fields. The system enables farmers to make informed decisions by detecting early symptoms of weeds, uneven emergence, nutrient deficiencies, disease or insect infestations, waterdamage, and machinery problems. Overseeing millions of acres of farmland in Argentina, Brazil, Russia, Ukraine, and the United States, Taranis gives farmers the tools to address issues in real-time, increasing yields and cutting costs. Taranis employs over 100 people worldwide and is headquartered in San Francisco with subsidiaries in Israel, Argentina, and Brazil. | $40M / Series D / Sep 07, 2022 | |
Datarails
|
DataRails is a financial planning and analysis platform that automates financial reporting and planning, while enabling finance teams to continue benefiting from the familiar spreadsheets and financial models of Excel. Automating these time-consuming manual processes paves the way for finance teams to spend more time analyzing data and less timegathering it. And it empowers them to answer essential strategic questions like what their organization can do to increase revenue and reduce expenses. | $50M / Series B / Mar 10, 2022 | |
MeMed
|
MeMed Diagnostics is a personalized diagnostics company founded in 2009. They are here to improve patient care, empower physicians, and lower health-care costs through rapid and actionable diagnostics for infectious diseases. Their main focus is preventing antibiotics misuse.Antibiotics are the most prescribed class of drugs worldwide with aglobal market of 25-30 billion $US. Up to 70% of antibiotics are estimated to be prescribed inappropriately, making them the most misused drug class in the world. Antibiotics misuse leads to ineffective treatment, emergence of resistant strains of bacteria, and is estimated to cost healthcare systems worldwide tens of billions of dollars annually. Their platform, the ImmunoDx™, leverages the world’s most accurate diagnostic system for differentiating bacteria from viruses, crafted by nature, the body’s immune system.ImmunoDx™ combines proprietary biomarkers, algorithms, and clinical know-how to identify the source of infection (virus vs bacteria, bacterial spectrum), by decoding the immune system`s differential response to different pathogens. This unique approach enables ImmunoDx™ to address some of the major challenges facing currently available diagnostics for infectious diseases. | $93M / Jan 10, 2022 | |
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
SaaS Investors
99,274 investors
Enterprise Investors
77,348 investors
Software Investors
50,021 investors
FinTech Investors
43,106 investors
Artificial intelligence Investors
40,702 investors
Financial Services Investors
26,626 investors
SaaS VC Funds
61,208 investors
Enterprise VC Funds
49,693 investors
Software VC Funds
31,919 investors
FAQ
What does La Maison Partners invest in?
La Maison Partners invests primarily in FinTech, Financial Services and Information Technology startups, most often at Series B and Series C stage. Most of the 18 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact La Maison Partners?
Public channels for La Maison Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at La Maison Partners?
The team at La Maison Partners includes Isabelle Amiel-Azoulai (Founding Partner), Marc Lévy (Founding Partner) and Michel Cicurel (Founding Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
